Pravat Mandal
Clinical trials sponsored by Pravat Mandal, explained in plain language.
-
New supplement trial aims to slow Parkinson's progression
Disease control Recruiting nowThis early-stage study tests whether a supplement called gamma-glutamylcysteine (GGC) can increase levels of a key antioxidant, glutathione, in the brains of people with early Parkinson's disease. Researchers will measure changes in brain chemistry, motor skills, thinking abiliti…
Phase: PHASE1 • Sponsor: Pravat Mandal • Aim: Disease control
Last updated May 26, 2026 10:44 UTC
-
Could a simple supplement shield the brain from repeated blows?
Disease control Recruiting nowThis early-stage trial is testing whether an oral supplement called gamma-glutamylcysteine (GGC) can increase a key antioxidant in the brain and blood of 30 people who have had repeated head impacts, such as retired NFL players and military veterans. The goal is to see if the sup…
Phase: PHASE1 • Sponsor: Pravat Mandal • Aim: Disease control
Last updated May 26, 2026 10:35 UTC